Evaluation of a New Therapeutic Strategy in Early and Active Relapsing-Remitting Multiple Sclerosis

NCT00219908 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
124
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Rennes University Hospital

Collaborators